# LYNOZYFIC

NDC: 61755-056
Generic name: linvoseltamab-gcpt
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20250702

FDA application: BLA761400

## Active ingredients

- LINVOSELTAMAB: 200 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-056"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-056
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9fd0739-1b3f-4b8b-824a-1f0a902384d3